Life Insurers Article on Think Advisor


In January 2019 Think Advisor published an article about how Wamberg Genomic Advisors and Cancer Guardian are demonstrating that “life insurers, brokers and employers could be good markets for tumor profile test benefits.”

“Tom Wamberg, the company’s chief executive officer, talked about his company during a recent interview in New York. Wamberg attended a LIMRA conference in an effort to persuade life insurers to add the company’s Cancer Guardian service package as a standard or add-on feature.”

“‘This is a tidal wave that’s coming,’ Wamberg said.”